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Introduction
The C Parallel Analyser (Kone Oy, Instrument Division,
Espoo, Finland) is a compact, new clinical analyser for
photometric equilibrium and kinetic analyses. The instrument
consists of a 24-channel parallel photometer, a control
console with numeric display, an alphanumeric printer and a
microcomputer which controls the analyser and takes care of
automatic blanking and calibration. Reaction mixtures are
prepared off line in additional system modules, Measurements
are made in blocks of 24 indiidually thermostated cuvettes
which are manually introduced into the analyser measurement
head. The same principle of parallel handling of the samples
simultaneously has been used in a bigger parallel analyser,
the System Olli 3000 ].
The instrument has been evaluated for the clinical assay
of seven tests which were selected to represent different
types of chemical determinations [2]. The tests evaluated
and their respective methods were as follows: alkaline
phosphatase (ALP, EC 3.1.3.1 kinetic), aspartate amino-
transferase (AST, EC 2.6.1.1; kinetic), alpha-amylase
(EC 3.2.1.1 chromogenic), albumin (equilibrium), cholesterol
(enzymatic equilibrium), creatinine (nonenzymatic kinetic)
and triglycerides (enzymatic kinetic). The results indicate
that the analyser is fast and versatile, and gives precise
results comparable with those obtained by methods routinely
used in the authors’ laboratory.
Materials and methods
Serum ALP and AST activities were determined according to
the method recommended by the Committee on Enzymes of
the Scandinavian Society for Clinical Chemistry and Clinical
physiology [3]. Both activities were measured routinely with
the LKB 8600 reaction rate analyser (L.KB-Produkter AB,
Bromma, Sweden) and with the C analyser. Using the C
analyser, the measurement was started within min of
adding the starting reagent. Reagents for ALP determination
were obtained from Orion-Yhtym/ Oy (Helsinki, Finland)
and for AST determination from Medix Oy (Kauniainen,
Finland).
Serum alpha-amylase activities were manually determined
with a Phadebas Amylase test (Pharmacia Diagnostics AB,
Uppsala, Sweden) using the procedure developed by the
manufacturer, and with the C analyser using the procedure
originally developed for the System Olli 3000 analyser [4].
The manual procedure was carried out using normal amylase
tablets (batch no CH 1141). The analyser procedure used
tablets which were half the weight of normal tablets (batch
no RLFA 770 404, Pharmacia Diagnostics AB).
Serum albumin, cholesterol and creatinine determinations
were carried out routinely with the SMAC (Technicon
Instruments Corp, Tarrytown, New York, USA)using the
original Technicon methods. (Technicon method no SG4-
0030PG5 (bromocresol green), SG4-0026PH5 (direct Lieber-
man- Burchard)and SG4o0011PJ4 (alkaline picrate, equili-
brium), respectively).
With the C analyser, serum albumin determinations were
made using the bromocresol green dye-binding method,
600pl of 0.9% NaC1 and 10ktl of serum sample were pipetted
into the cuvettes in the measuring block, and 800/.d of
bromocresol green reagent (General Diagnostics AB, Division
of Warner-Lambert Co, Morris Plains, New Jersey, USA)
was added simultaneously using the dispenser. The measure-
ment was carried out min after addition of the dye-reagent.
Serum cholesterol concentrations were determined
enzymatically with the C analyser using a test kit "Test-
Combination Cholesterol (CHOD-PAP)" (no 187 313,
Boehringer Mannheim, Mannheim, West-Germany)as directed
by the manufacturer. Calibration was performed using 7.5
mmol/1 of aqueous cholesterol standard (Orion-Yhtymii Oy).
Serum creatinine concentrations were determined kine-
tically with the C analyser using a "Mercotest, Creatinine"
test kit (no 3384, E Merck AB, Darmstadt, West-Germany).
Reagents were prepared as directed by the manufacturer
and the following procedure was used: 1.0 ml of a picric
.acid reagent and 100/1 of serum sample were pipetted into
the cuvettes in the measurement block. The block was then
shake.n and incubated for 15 min at 37C. Measurement
was started within min 30 sec of adding 100/al of the
buffer solution to the cuvettes with the dispenser. The
measurement time was 2 rain.
Serum triglyceride concentrations were routinely deter-
mined enzymatically by an equilibrium, method using a
"Triglycerides, fully enzymatic" test kit (no 126 039,
Boehringer Mannheim) as described earlier [5]. With the
C analyser, triglyceride concentrations were determined
kinetically using a.test kit "Triglycerides, fully enzymatic
kinetic UV-method" (no 244 473, Boehringer Mannheim).
The procedure was similar to that proposed for the LKB
reaction rate analyser by the manufacturer except that the
measurements were started within 30 sec of adding the
glycerol kinase reagent. Calibration was performed using
2.0 mmol/1 of aqueous glycerol standard.
Apparatus
The C Parallel Analyser consists of a 24-channel parallel
photo’meter (with max. 12 interference filters covering
the range 340-800 nm, absorbance range 0.000-2.000,
bandwidth 8 nm in UV-filters and 10-15 nm in visible range
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Figure 1. Principle of the photometer.
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filters). It includes a control console with numeric display,
an alphanumeric thermal printer and a microcomputer
(8-bit). The analyser is designed to perform both equilibrium
and kinetic determinations in batches of 24 (or less) samples;
the minimum end volume is 500pl. Light from a single
source (Xenon-lamp) is supplied by quartz-fibre optics to
an array of 24 individual detectors. The operating principle
is shown in Figure 1. A fixed arrangement of the sample
cups, cuvettes and dispensing tips is used. Reaction mixtures
are introduced into the photometer in thermostated
aluminium blocks of 24 cuvettes, in which they are also
prepared and preincubated using a range of additional system
modules- parallel dispenser 216, incubator 354, mixer 369.
and centrifuge. The block is manually transferred between
modules. Dispensing order, volumes and incubation times
may be selected according to the requirements of a particular
assay method.
The 216 dispenser is a parallel dispenser for 24 samples or
reagents. The reagents are poured into each cup, which may
be filled in advance and transferred to the dispenser as
needed. When dispensing, a disposable tip is used for each
sample to eliminate cross contamination or carry over
between the samples. Aspiration of a sample from a specimen
can also be performed manually using a Multipipette which is
a four-channel hand-pipette especially designed for the system
cuvette blocks, or by using a semi-automatic diluter (eg the
Micromedic automatic pipette model 25002, Micromedic
System Ins, Philadelphia, USA).
The reaction temperature is maintained with an accuracy.
of + 0.1C of the set temperature and a between variation of
+ 0.05C by heating circuits in the block. The temperature of
Figure 2. Listing of all parameters used for the test.
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the cuvette block can be checked before the measurement by
pressing the CUVETTE TEMP key on the control module.
The analyser has been programmed for ten different
equilibrium or kinetic methods (selected by the user), each
of which is characterised by 16 different variable parameters.
A list of parameters is shown in Figure 2. This includes the
measuring mode, whether the measurement is kinetic or
equilibrium, the wavelength, the temperature (25, 30, 35 or
37 C), the measurement time for kinetic methods (1 to 10 min
variable in steps of min), the direction of the kinetic
reaction, the number and concentration of standards, possible
factors used in calculating the results, and the minimum and
maximum allowed limits for a kinetic reaction. Because these
parameters are variable, the user is not bound to ten methods.
The changeover from one method to another or the
modification of the parameters is performed through the
keyboard. This is shown in Figure 3. To change the method
the METHOD NUMBER key, the desired numeric key and
the ACCEPT key are pressed. The parameters of the newly
selected method are then valid. To alter the value of a
parameter the PARAM NUMBER key, the number of the
desired parameter and the ACCEPT key are pressed followed
by the new value and the ACCEPT key. All the altered para-
meters are valid until the power is switched off. The LIST
function displays the valid parameters for checking.
Standards, if use, are analysed simultaneously with the
samples. The calibration curve is calculated from these
standard samples using a straight line fit. In equilibrium
methods the concentration of the samples are calculated
with the aid of factors which result from the calibration or
which are entered by the user through the keyboard (maximal
factor 9999). In kinetic methods 12 absorbance readings are
measured for each standard and sample (the first readings
can be made within 30 seconds after initiation of the reaction).
The rates (dA/min) are calculated using a straight line fit.
The concentrations are calculated as explained above.
Very recently Kone Oy, Instrument .Division has intre-
duced a parallel 8,channel sample processor "D", which
performs the dispensing, mixing and incubation of samples
and reagents completely automatically in the cuvette block.
Results and discussion
Rate of analyses
It was possible to analyse 24 samples (one block containing
usually four standard and 20 serum samples) in 10 min for
albumin, 35 min for alpha-amylase and 25 min for the
other methods with incubation periods included. If the
pipetting of the following blocks was started during the
incubation period of the first block, 2-3 more blocks could
be assayed in about 15 min for all the analyses tested.
Figure 3. The keyboard of the C Parallel A nalyser.
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Table 1. Within-day and day-to-day precision (n 20) of the tests on the C Parallel Analyser.
Test
ALP, U/1 37C
AST, U/1 37C
Amylase, U/I 37C
Albumin, g/1
Cholesterol, mmol/1
Creatinine, mol/1
Triglycerides, mmol/1
w, m-u y "":th’-’- -a-’"
Low CV% mean
80.6 2.6
14.0 2.5
82.2 2.3
27.2 1.6
3.54 1.7
44.4 2.5
0.81 2.7
Medium
mean
195.4
40.6
177.1
38.9
5.55
84.8
1.62
cv%
i.9’
1.7
2.1
1.7
0.9
2.5
2.4
High
mean
"’ 3o.8
226.3
946.5
47.3
10.1
702.7
4.52
CV% Medium
mean
1.5 188.3
1.7 35.2
3.0 213.3
1.0 39.5
0.9 5.62
0.6 87.1
2.3 1.61
cv%
2.8
4.9
4.7
1.6
2.1
3.6
4.4
Table 2. Within-day precision of the whole system when different types of pipettes were used in serum sample pipetting
(n 20).
Test
Albumin, g/1
Total protein*, g/1
AST, U/1 370C
Sample/reagent volume (1)
10/1400
10/1000
20/2000
50/5000
150/1100
* Biuret method Mercotest no 3327 (E Meck AB).
Micromedic pipette
mean CV%
38.9 1,7
69.8 1.0
70.6 0.5
70.9 0.4
24.3 2.4
Four,, channel hand Pipett’e
mean CV%
39.3 5.6
74.1 11.3
71.8 2.8
70.7 1.3
23.1 2.7
1.0
0.2
0.1
A LBUM N 1.0
0.5
.129
r 0.999
30 60
g/I
0.16
CREATININE
._=
E
<
0.08
00104 x + 0.001
r 0.996
10"-’00 2000
umol/I
CHOLESTEROL
r 0.999
g
mmol/I
TR IGLYCE
y- 0.0136 x + 0.001
r.O. 999
5 10
mmol/I
Figure 4. Linearity of albumin, cholesterol, creatinine and triglycerides tests on the CParallel Analyser, determined using
dilutions ofaqueous standards and patient sera with high concentration (o).
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Precision
The within-day precision was evaluated by analysing speci-
mens of sera at three different levels of concentration or
activity of analytes (low, medium and high).(n 20), and
day-to-day precision at one concentration or activity of
analytes (n 20). The mean values and variation coefficients
are given in Table 1. Both within-day and day-to-day precisions
were good, generally less than 3.0% and 5.0%, respectively.
A Micromedic diluter or a 24channel dispenser were
used in sample pipetting. The Micromedic diluter was always
used for serum volumes below 50pl, because earlier experience
indicated that the smallest serum volume which can be
reliably dispensed with the 24-channel dispenser is 50pl [6].
The suitability of the four-channel hand-pipette in serum
sample pipetting was also tested. The pipette gave acceptable
precision above 50pl, but under this volume it was found to
be more reliable to use a diluter (Table 2).
The new parallel 8-channel sample processor "D" was also
evaluated. From preliminary results on this machine the
precision within blocks (20 different blocks were tested) was
1.2% and 1.0%, when 10 and 50/.tl volumes of.p-nitrophenol
in serum plus 550pl of buffer were pipetted and the absor-
bances were measured at 405 nm. This indicates that pro-
blems in the pipetting of small sample volumes for parallel
analysers can probably be solved using this instrument.
Linear range
Linearity of the methods was determined using aqueous
standards and specimens containing high concentrations or
activities of the various constituents. These were diluted
with 0.9% NaC1 before analysis to cover a range of values.
The range of linearity for ALP and AST was found to,beat
least up to ten times the upper limit of the normal.reference
range (not shown), for alpha-amylase up to 1000 U/1 (not
shown), for albumin at least up to 65 g/1 (Figure 4), for
cholesterol at least up to 11.0 mmol/1 (Figure 4), for creatinine
up to 1500btmol/1 (Figure 4) and for triglycerides up to
9.0 mmol/1 (Figure 4). These ranges were sufficiently extensive
to allow most specimens to be analysed without dilution.
In addition, Figure 4 shows the sensitivity of the methods.
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Figure 5a (above) and 5b (opposite). Comparison o[patient values between the methods used routinely in the authors’
laboratory (x) and in the C ParallelA nalyser (y).
156 Journal of Automatic ChemistryPuukka & Puukka -.Evaluation of the new "C" parallel analyser
Comparison of patient sera
Analyte concentrations or activities obtained by the C
analyser methods were compared with the values obtained
from the procedures routinely used in the authors laboratory
(except for alpha-amylase). All such comparisons were made
on the same day within 1/2-3 hours of each other, 100 patient
sera being used for each comparison .(58 for triglycerides).
A summary of the correlation and regression data is.given in
Figure 5. Correlation coefficients obtained were 0.916 for
albumin values, 0.977 for cholesterol values and over 0.99
for the others.
The poor correlation obtained for albumin values probably
reflects a variation caused by the reagents and/or the reaction
conditions (cf work by Spencer and Price [7])rather than
instrument variability. The albumin values obtained from the
procedure used in the Technicon SMAC do not compare well,
with values obtained by the more specific methods [8].
In ALP and AST studies, for which the same methods
were used on both the LKB reaction rate analyser and the
C analyser, slopes close to 1.00 were obtained. A slight
difference in the slope for ALP could not be due to a variation
in the optical characteristics of the filters of the two instru-
ments, because 405 nm filters were calibrated using solutions
of p-nitrophenol ofknown absorbance. Several other explana-
tions are possible as different types of pipette and different
measurement time intervals were used. In addition, the
primary data were analysed differently.
When using the C analyser for alpha-amylase deter-
minations it was not possible to use a computer to obtain
results as in a bigger parallel analyser, the System Olli 3000
[4], which offers the more complicated programs for non-
linear calibration curves. The results were consequently
calculated manually-with the aid of the Pharmacia standard
curve. Higher results obtained with the C analyser ,.,can be
explained both by differences between different batches of
the substrate and too high an incubation temperature for the
reactions. The temperature of the incubator 354 is 37.5
37.6C because it has been designed especially for the pre-
incubation of the kinetic analysis ].
In view of the different methods and the different stan-
dards used, the correlation data for cholesterol (enzymatic/
non-enzymatic method), creatinine (kinetic/equilibrium
method) and triglycerides (kinetic/equilibrium method) were
considered acceptable. In the kinetic method for the deter-
mination of triglycerides especially, the control of the
reaction temperature and the exact timing of the measure-
ments were necessary to obtain accuracy and precision.
1000
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Error messages
The error detection system in the C analyser adds validity to
the answers. A series of messages are used which indicate
whether or not there are errors in calibration or in the
reaction temperature, that the initial absorbance of the
kinetic, reaction is too high .or too low, that the reaction rate
curves fail to satisfy the linearity criteria etc. However, the
linearity error code is printed only if the linearity error is
greater than 20%. The acceptability limits of linearity should
be smaller and/or the operator should be able to select a
value for them. The graphical print-out of kinetic measure-
ments is not possible in the C analyser, as it is in the System
Olli 3000 analyser. However, if the error message indicates
the nonlinear reaction, the user can check how the reaction
is proceeding by using RATE DATA key. Rate data consists
of (1) four abosrbance values, which are mean values of
three successive readings, (2) three dA/min values obtained
from the successive mean absorbances respectively, and
(3) results in concentration units, which are calculated for
each dA/min. The error messages are not included in the
programs of the System Olli 3000 analyser.
Reliability
The primary purpose of this evaluation was to test the
suitability of the C .Parallel Analyser for the laboratories
in the district of Oulu University Central Hospital. During
the two months of the evaluation period no service was
needed. After the analyser had been in Oulu City Hospital
for one year, the downtime was three days, one due to the
change of the UV-filter, and two due to the repairof the
ignition unit for the Xenon-lamp. Additionally, the timer
of the preincubator was broken, but it did not hold up
work. In Oulu City Hospital the analyser is used for five days
weekly and about 300 analyses are performed daily.
Conclusion
The C Parallel Analyser has proved to be an instrument with
good reliability and precision. Advantages were the speed of
analysis, the ability to change chemistries easily and quickly,
versatility in accommodating kinetic and equilibrium tests
equally well, and the ease with which methods can be modi-
fied. The ease of operation is impressive and the operator
can learn, the leyboard manipulations rapidly. Errors and
malfunctions are indicated through a thermal printer. Because
standards and samples can be analysed in parallel, the C
analyser has much potential especially in the kinetic analyses
of serum nonenzymatic constituents. However, because the
first readings can be made only .within" 30 seconds after
initiating the reaction, analyses of very rapid kinetic reactions,
for instance kinetic turbidimetric assays of serum immuno-
globulins are difficult. The C analyser also lacks a graphic
printer.
A semi-automatic diluter (or the D parallel sample pro-
cessor) is needed for the pipetting of small sample volumes.
The analyser should have an application in performing a
range of analyses in laboratories where around 150-600 daily
analyses are performed and it is also suitable for the analysis
of emergency samples.
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Erratum
The Journal ofAutomatic Chemistry, April 1980, 2, 2, 66-75.
A compact automated microprocessor-based flow analyser
Michael A. Koupparis, Ken M. Walczak and
Howard V. Malmstadt
The authors have asked that the following errors in the above On p73, in the first complete paragraph, the sixth and seventh
paper be brought to the attention of the readers, sentences should read, "The minimum volume required to
move the old solution from the cell (dead volume of mixer,
flow cell, and their connections) was found to be 100
On p71, the second sentence of the fourth paragraph should 100-25/al can be chosen by adjusting the mechanical stoppers
read, "The to 0 transition was chosen as the power-on of the automatic pipetter."
state of the parallel I/O ports to ensure that the control
signals were not activated when power was applied to the On p74, the ascorbic acid standards of the text and in Table
microcomputer or a reset sequence was initiated." 5 were made of 5-40 mg/1 in 0.05M oxalic acid solution.
On p75, in the table of References, the fifth reference was
On p71, the final paragraph should state, "The absorbance published in 1977.
measurements, of Table 2 were carried out at 520 mm." On p74, the slope in Table 5.should read-0.02366.
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